UPSHER-SMITH 50 mg Pill: gray & yellow, capsule/oblong, 8mm
The pill with imprint UPSHER-SMITH 50 mg (Gray & Yellow, Capsule/Oblong, 8mm) has been identified as Topiramate Extended-Release 50 mg and is used for Lennox-Gastaut Syndrome, Migraine Prevention, Epilepsy, Seizure Prevention, and Seizures. It belongs to the drug class carbonic anhydrase inhibitor anticonvulsants and is not a controlled substance.
Images for UPSHER-SMITH 50 mg
Topiramate Extended-Release
- Imprint
- UPSHER-SMITH 50 mg
- Strength
- 50 mg
- Color
- Gray & Yellow
- Size
- 8.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Upsher-Smith Laboratories, Inc.
- Inactive Ingredients
-
microcrystalline cellulose,
hypromellose 2910 (6 mPa.s),
ethylcellulose (10 mPa.s),
diethyl phthalate,
titanium dioxide,
ferrosoferric oxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00245-1072 | Upsher-Smith Laboratories Inc. |
| 00832-1072 | Upsher-Smith Laboratories Inc. |
Related images for "UPSHER-SMITH 50 mg"
Featured
Semaglutide
Semaglutide is a GLP-1 agonist used for weight loss, type 2 diabetes, and reducing cardiovascular ...
Reviews & ratings
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,343)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR, Topiragen
Professional resources
- Topiramate monograph
- Topiramate (FDA)
- Topiramate Capsules (FDA)
- Topiramate ER Capsules (FDA)
- Topiramate Oral Solution (FDA)
- Topiramate Tablets (FDA)
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.